Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence

Clinical trial NCT01178281 · COMPLETED

Trial details

NCT number: NCT01178281
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Myelofibrosis MPN-associated Myelofibrosis

Start date: 2010-09-08
Primary completion: 2013-01-01
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.